AstraZeneca's dental business in Italy acquired by American Dentsply International

AstraZeneca's dental business in Italy acquired by American Dentsply International In its press statement of January 19, AstraZeneca, the current distributor of Carisolv in Italy, announced that Dentsply International would be taking over sales of local anaesthetic for dental care on all markets. As a result, the entire Italian AstraZeneca dental operation would be taken over by the Italian subsidiary of Dentsply. Dentsply is recognised as the world's leading company in development, manufacturing and distribution of material and products for the dental market. The company distributes its dental products in over 100 countries under some of the most well established brand names in the industry. MediTeam has been informed that the market development of Carisolv in Italy will proceed according to plan. For further details, please contact: Annette Ravenshorst Claes Holmberg Vice President Corporate & President and CEO Marketing Communications Phone: +46 31-336 91 21 Phone: +46 31-336 91 01 Mobile. +46 709-72 62 86 Mobile +46 708-25 45 47 MediTeam is a Swedish research-oriented dental company that markets new treatments world wide based on odontological research. It is currently developing and marketing Carisolv - a tissue-preserving method for the removal of caries with minimum trauma and pain for the patient. www.mediteam.com MediTeam Dental AB (publ). Göteborgsvägen 74. S-433 63 Sävedalen. Sweden. Phone +46 31-336 91 00. Fax +46 31-336 91 91. ------------------------------------------------------------ This information was brought to you by BIT http://www.bit.se The following files are available for download: http://www.bit.se/bitonline/2001/01/23/20010123BIT00740/bit0001.doc http://www.bit.se/bitonline/2001/01/23/20010123BIT00740/bit0002.pdf